CoREST complex inhibition alters RNA splicing to promote neoantigen expression and enhance tumor immunity
Robert Fisher(Boston University), Rhoda M. Alani(Boston University), Christina Ennis(Boston University), Shadmehr Demehri(Massachusetts General Hospital), Kwangwoon Lee(Brigham and Women's Hospital), Kihyun Park(Boston University), Eunju Nam(Brigham and Women's Hospital), Catherine J. Wu(Broad Institute), Eric H. Raabe(Johns Hopkins University), Simone Sidoli(Albert Einstein College of Medicine), Ana Fiszbein(Boston University), Katarina Pinjušić(Harvard University), Stephanie Stransky(Albert Einstein College of Medicine), Chad W. Hicks(Johns Hopkins University), Hanjie Jiang(Johns Hopkins University), Scott B. Ficarro(Harvard University), Parisa Farokh(Harvard University), Jarrod A. Marto(Dana-Farber Cancer Institute), Derin B. Keskin(Dana-Farber Cancer Institute), Allison P. Vanasse(Dana-Farber Cancer Institute), Anupa Geethadevi(Bloomberg (United States))
Cited by 0
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.4k
Towards personalized, tumour-specific, therapeutic vaccines for cancer
|Nature reviews. Immunology|2017|1k